Comparative study on glycosaminoglycans synthesized in peripheral and peritoneal polymorphonuclear leucocytes from guinea pigs
- PMID: 6696721
- PMCID: PMC1153197
- DOI: 10.1042/bj2170199
Comparative study on glycosaminoglycans synthesized in peripheral and peritoneal polymorphonuclear leucocytes from guinea pigs
Abstract
Glycosaminoglycans synthesized in polymorphonuclear (PMN) leucocytes isolated from blood (peripheral PMN leucocytes) and in those induced intraperitoneally by the injection of caseinate (peritoneal PMN leucocytes) were compared. Both peripheral and peritoneal PMN leucocytes were incubated in medium containing [35S]sulphate and [3H]glucosamine. Each sample obtained after incubation was separated into cell, cell-surface and medium fractions by trypsin digestion and centrifugation. The glycosaminoglycans secreted from peripheral and peritoneal PMN leucocytes were decreased in size by alkali treatment, indicating that they existed in the form of proteoglycans. Descending paper chromatography of the unsaturated disaccharides obtained by the digestion of glycosaminoglycans with chondroitinase AC and chondroitinase ABC identified the labelled glycosaminoglycans of both the cell and the medium fractions in peripheral PMN leucocytes as 55-58% chondroitin 4-sulphate, 16-19% chondroitin 6-sulphate, 16-19% dermatan sulphate and 6-8% heparan sulphate. Oversulphated chondroitin sulphate and oversulphated dermatan sulphate were found only in the medium fraction. In peritoneal PMN leucocytes there is a difference in the composition of glycosaminoglycans between the cell and the medium fractions; the cell fraction was composed of 60% chondroitin 4-sulphate, 5.5% chondroitin 6-sulphate, 16.8% dermatan sulphate and 13.9% heparan sulphate, whereas the medium fraction consisted of 24.5% chondroitin 4-sulphate, 28.2% chondroitin 6-sulphate, 33.7% dermatan sulphate and 10% heparan sulphate. Oversulphated chondroitin sulphate and oversulphated dermatan sulphate were found in the cell, cell-surface and medium fractions. On the basis of enzymic assays with chondro-4-sulphatase and chondro-6-sulphatase, the positions of sulphation in the disulphated disaccharides were identified as 4- and 6-positions of N-acetylgalactosamine. Most of the 35S-labelled glycosaminoglycans synthesized in peripheral PMN leucocytes were retained within cells, whereas those in peritoneal PMN leucocytes were secreted into the culture medium. Moreover, the amount of glycosaminoglycans in peritoneal PMN leucocytes was significantly less than that in peripheral PMN leucocytes. Assay of lysosomal enzymes showed that these activities in peritoneal PMN leucocytes were 2-fold higher than those in peripheral PMN leucocytes.
Similar articles
-
Proteoglycans synthesized by human polymorphonuclear leucocytes in vitro.Immunol Cell Biol. 1989 Feb;67 ( Pt 1):9-17. doi: 10.1038/icb.1989.2. Immunol Cell Biol. 1989. PMID: 2498202
-
Changes in glycosaminoglycan biosynthesis during differentiation in vitro of human monocytes.Biochem J. 1983 Mar 15;210(3):661-7. doi: 10.1042/bj2100661. Biochem J. 1983. PMID: 6870801 Free PMC article.
-
Synthesis of glycosaminoglycans by human embryonic lung fibroblasts. Different distribution of heparan sulphate, chondroitin sulphate and dermatan sulphate in various fractions of cell culture.Biochem J. 1977 Nov 1;167(2):383-92. doi: 10.1042/bj1670383. Biochem J. 1977. PMID: 202253 Free PMC article.
-
Chondroitinase as a therapeutic enzyme: Prospects and challenges.Enzyme Microb Technol. 2024 Jan;172:110348. doi: 10.1016/j.enzmictec.2023.110348. Epub 2023 Oct 21. Enzyme Microb Technol. 2024. PMID: 37898093 Review.
-
Methods for analysis of urinary glycosaminoglycans.J Chromatogr. 1988 Jul 29;429:293-313. doi: 10.1016/s0378-4347(00)83875-x. J Chromatogr. 1988. PMID: 3062022 Review.
Cited by
-
Chondroitin sulphate structure affects its immunological activities on murine splenocytes sensitized with ovalbumin.Biochem J. 2004 Aug 15;382(Pt 1):269-78. doi: 10.1042/BJ20031851. Biochem J. 2004. PMID: 15147241 Free PMC article.
-
Immunological activity of chondroitin sulfate.Adv Pharmacol. 2006;53:403-15. doi: 10.1016/S1054-3589(05)53019-9. Adv Pharmacol. 2006. PMID: 17239777 Free PMC article. Review. No abstract available.
-
An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.Int J Nanomedicine. 2014 Nov 19;9:5341-53. doi: 10.2147/IJN.S68966. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25429219 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources